avanafil

Generic: avanafil

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name avanafil
Generic Name avanafil
Labeler camber pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

avanafil 100 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-441
Product ID 31722-441_46258a47-8730-8397-e063-6394a90a6478
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209266
Listing Expiration 2026-12-31
Marketing Start 2024-06-14

Pharmacologic Class

Established (EPC)
phosphodiesterase 5 inhibitor [epc]
Mechanism of Action
phosphodiesterase 5 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722441
Hyphenated Format 31722-441

Supplemental Identifiers

RxCUI
1291306 1291365 1291369
UPC
0331722442305 0331722440301 0331722441308
UNII
DR5S136IVO
NUI
N0000175599 N0000020026

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name avanafil (source: ndc)
Generic Name avanafil (source: ndc)
Application Number ANDA209266 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (31722-441-01)
  • 30 TABLET in 1 BOTTLE (31722-441-30)
source: ndc

Packages (2)

31722-441-01 100 TABLET in 1 BOTTLE (31722-441-01) 31722-441-30 30 TABLET in 1 BOTTLE (31722-441-30)

Ingredients (1)

avanafil (100 mg/1)

Linked Drug Pages (1)

Avanafil ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "46258a47-8730-8397-e063-6394a90a6478", "openfda": {"nui": ["N0000175599", "N0000020026"], "upc": ["0331722442305", "0331722440301", "0331722441308"], "unii": ["DR5S136IVO"], "rxcui": ["1291306", "1291365", "1291369"], "spl_set_id": ["1d04e17d-7399-430a-a8bb-fa1912b155e9"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (31722-441-01)", "package_ndc": "31722-441-01", "marketing_start_date": "20240614"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (31722-441-30)", "package_ndc": "31722-441-30", "marketing_start_date": "20240614"}], "brand_name": "Avanafil", "product_id": "31722-441_46258a47-8730-8397-e063-6394a90a6478", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "31722-441", "generic_name": "Avanafil", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Avanafil", "active_ingredients": [{"name": "AVANAFIL", "strength": "100 mg/1"}], "application_number": "ANDA209266", "marketing_category": "ANDA", "marketing_start_date": "20240614", "listing_expiration_date": "20261231"}